Please login to the form below

Paul Hudson

This page shows the latest Paul Hudson news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Sobi’s once-weekly haemophilia A treatment approved by FDA

Sanofi’s chief executive officer, Paul Hudson, said: "This approval of Altuviiio allows patients and physicians to reimagine living with haemophilia… For the first time, with a once-weekly dose, powerful

Latest news

Sanofi Global Health unveils new nonprofit Impact brand

Paul Hudson, chief executive officer at Sanofi said: “With critical medicines, relentless drive and impactful partnerships, we can take our innovation beyond the lab and use it to strengthen health systems
Sanofi launches new funding foundation

Paul Hudson, CEO at Sanofi, concluded: “The launch of Foundation S is a new cornerstone of Sanofi’s commitment to society and a pivotal moment for the life of our company
Sanofi and McLaren Racing come together to maximise performance and operational excellence

Paul Hudson, CEO of Sanofi, said: “I see a lot of commonalities in our shared values to stretch, with courage and determination, so we can maximise performance and operational excellence.
Sanofi launches Diversity, Equity & Inclusion Board

Paul Hudson, CEO of Sanofi, said: “We’re committed to driving diversity, equity and inclusion in Sanofi and beyond. ... Made up of eleven members, including seven members from Sanofi’s leadership, the DE&I Board includes Paul Hudson, chief
Sanofi unveils new corporate brand and logo

Speaking about the new developments at Sanofi, Paul Hudson, CEO, said: “As we approach the half century mark of our company’s existence, we have undertaken the most important transformation and

More from news
Approximately 3 fully matching, plus 32 partially matching documents found.

Latest Intelligence

20 for 2020 – Five pharma leaders to watch in 2020

3. Paul Hudson – taking the helm at Sanofi. Another new chief executive with a lot on his plate in 2020 is Paul Hudson, who took over from Olivier Brandicourt at French ... Hudson takes over Sanofi at a transitional time for the French group, which
Integrating patient reported outcomes into clinical trials

In explaining how his company designs its R&D portfolio, Johnson &Johnson chief scientific officer Paul Stoffels said “quality of life is the first metric” on a 2019 conference call with ... The quality-of-life data is probably one of the single
NHS regional footprints

By Steve How, Paul Midgley and Oli Hudson, all part of Wilmington Healthcare’s Consulting Team, see www.wilmingtonhealthcare.com.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Covid-19 drives change in long-term conditions management

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home. ... delivery. The time for digitally-supported pharma products is now. Ends. Paul Midgley is Director of NHS Insight and
Covid-19: how is it impacting on the NHS Long-term Plan?

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy. ... Ends. Oli Hudson is Content Director and Paul Midgley is Director of NHS Insight, both at Wilmington
How will the Tories’ historic win shape the NHS?

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.
2019: A pivotal year for the NHS

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the key changes in the NHS in 2019. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.
Early diagnosis underpins NHS cancer strategy

Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan. ... Ends. Paul Midgley is Director of NHS Insight; Sarah Shield is a Consultant and Oli Hudson is Content Director

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

No results were found

PMHub

Add my company

Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The 17th World Congress on Controversies in Neurology: This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success: In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge: Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Email:
Password:

Please login to the form below

Paul Hudson

Subscribe to our email news alerts

Quick links